ArticleMedical physics2025
Advancing free-breathing liver diffusion-weighted imaging with Propeller-EPI: Improved image quality and ADC repeatability.
Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diffusion MRI of the Body: Beyond PGSE-EPI.Journal of magnetic resonance imaging : JMRI · 2026Review
- Advancing free-breathing liver diffusion-weighted imaging with Propeller-EPI: Improved image quality and ADC repeatability.Medical physics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundLiver diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) measurement has proven valuable in diagnosing liver diseases. In certain patient populations, a free-breathing (FB) liver DWI approach is desirable to improve patient comfort and broaden clinical applicability. However, maintaining high image quality under FB conditions and achieving satisfactory ADC repeatability can be challenging when using routine diffusion-weighted single-shot echo-planar imaging (DW-ss-EPI). PURPOSE: This study aimed to develop an advanced FB liver DWI technique based on diffusion-weighted Propeller echo-planar imaging (DW-Propeller-EPI) to achieve motion compensation, and to prospectively evaluate its performance in terms of image quality and ADC repeatability compared to standard DW-ss-EPI.
methodsA DW-Propeller-EPI pulse sequence and reconstruction pipeline was developed on a 1.5T MRI system. The pipeline incorporated a reference-free Nyquist ghost correction method and motion compensation using correlation weighting during data reconstruction. For in vivo evaluation, participants prospectively underwent two repeated liver DWI scans using four techniques: three routine DW-ss-EPI sequences with different breathing controls (breath-holding, BH; respiratory-triggering, RT; and FB), and one FB DW-Propeller-EPI sequence. The raw data from the FB DW-Propeller-EPI scans were processed offline with the developed motion-compensated reconstruction. Two radiologists independently rated the image quality on a 5-point scale across five aspects (signal homogeneities in the left lobe, geometric fidelity, liver edge sharpness, vessel clarity, and overall image quality). Mean scores were compared among the four techniques using the Friedman test. The repeatability of ADC measurements was evaluated with Bland-Altman analysis, and differences in ADC values between liver lobes and techniques were analyzed using two-way repeated measures ANOVA.
results35 participants were enrolled, with twenty completing repeated scans. FB DW-Propeller-EPI demonstrated significantly higher ratings than the three routine DW-ss-EPI sequences across all aspects (all P < 0.001), with good interobserver agreements (ICC ranging from 0.80-0.88). The mean geometric fidelity score of FB DW-Propeller-EPI was rated the highest (4.86 ± 0.33). FB DW-Propeller-EPI also exhibited superior ADC repeatability in both the left and right liver lobes (LOA: 0.212 × 10
conclusionsThe proposed FB DW-Propeller-EPI technique enables high-quality FB liver DWI with satisfactory ADC repeatability, outperforming conventional DW-ss-EPI in image quality and ADC repeatability. This advancement addresses the limitations of routine DW-ss-EPI in FB scenarios, offering a promising solution for clinical applications in challenging population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.